PARIS: Taking a brand new era of weight-loss treatment is linked to a considerably decrease threat of dependancy and loss of life from medicine akin to cocaine and alcohol, a big US examine urged on Thursday.
The massively fashionable medicine generally known as GLP-1 agonists might even halve folks’s threat of dying from a spread of dangerous substances, in keeping with the analysis printed within the BMJ journal on Thursday.
Nevertheless exterior specialists urged warning in deciphering the outcomes, which don’t set up a causal hyperlink, calling for medical trials to search out out extra.
As GLP-1 medicine akin to Ozempic have remodeled the remedy of diabetes and weight problems lately, they’ve additionally proven indicators of serving to with a shocking number of well being issues — together with dependancy.
The US staff of researchers analysed the medical information of greater than 600,000 folks with kind 2 diabetes within the US Division of Veterans Affairs’ healthcare database who took both GLP-1s or an older type of diabetes drug.
The researchers then appeared on the impact of medication together with alcohol, hashish, cocaine, nicotine and opioids over three years.
For veterans who already had a drug dependancy, taking GLP-1s had a 50% decrease fee of loss of life and a 40% decrease fee of overdose.
The speed of emergency division visits was greater than 30% decrease, whereas hospital admissions and suicidal ideas or makes an attempt had been down by 1 / 4.
Amongst veterans with no historical past of drug dependancy, taking GLP-1s was linked with a 14% decrease threat of creating one.
‘Fairly a shock’
Ziyad Al-Aly, an epidemiologist at Washington College in St Louis and the examine’s senior creator, advised AFP it was “fairly a shock” what number of substance-use issues the GLP-1s appeared to forestall.
“The impact was not confined to at least one substance, it was evident throughout the board for all addictive substances,” he advised AFP.
The analysis is observational, so can’t instantly show that the GLP-1s brought about the outcomes seen within the examine.
And precisely how these appetite-suppressing medicine might struggle dependancy stays unclear. Nevertheless there have been solutions they might have an effect on how our brains reward sure behaviours.
The researchers additionally warned that the contributors had been largely older white males — although the outcomes appeared constant for girls as properly.
Fares Qeadan, a biostatistics skilled at Loyola College Chicago not concerned within the analysis, mentioned the “implications are pragmatic moderately than revolutionary”.
“Policymakers ought to due to this fact keep away from untimely ‘Ozempic for dependancy’ narratives,” Qeadan mentioned in a linked editorial within the BMJ.
And even when medical trials verify these medicine are efficient towards dependancy, they’re costly and never obtainable equally to all nations, he added.
